Article Figures & Data
Tables
Demographic and clinical characteristics of healthy controls and patients with active, remitted, and cured CSa
Healthy Controls Patients with Active CS Patients with Remitted CS Patients with Cured CS F/χ2 P Value Age (yr) 42.3 ± 10.4 41.9 ± 8.7 47.1 ± 10.0 41.4 ± 10.0 5.9 NS Sex (M/F) 6:29 1:7 1:6 4:16 0.3 NS Years of education 13.5 ± 3.4 14.4 ± 3.0 12.9 ± 2.3 13.4 ± 3.1 0.3 NS 24-Hour urinary free cortisol 133 ± 52 543 ± 307 152 ± 74 122 ± 75 26.3 <.001b Smoking status (nonsmoker/smoker/ex-smoker) 12/12/11 7/1/0 2/4/1 9/5/6 10.4 NS Disease duration (mo) NA 77.6 ± 77.4 44.6 ± 21.9 64.6 ± 34.0 0.99 NS Origin (pituitary/adrenal/ectopic/AIMAH) NA 5/3/0/0 3/2/1/1 17/2/0/0 10.8 NS Hypertension (no/yes) 35/0 4/4 3/4 13/7 20.9 <.001c Hypercholesterolemia (no/yes) 31/4 7/1 7/0 17/3 1.2 NS Hypertriglyceridemia (no/yes) 29/6 6/2 3/4 9/11 10.5 .015d Central obesity (no/yes) 25/10 2/6 0/7 9/11 15.6 .001e Body mass indexg (no/overweight/obesity) 22/11/2 2/5/1 1/3/3 8/9/3 12.6 .049f Note:—NS indicates not significant; AIMAH, ACTH-independent macronodular adrenal hyperplasia.
↵a Data are expressed as mean ± SD.
↵b Healthy controls vs active CS (<.001); active CS vs remitted CS (<.001); active CS vs cured CS (<.001).
↵c Healthy controls vs active CS (<.001); healthy controls vs remitted CS (<.001); healthy controls vs cured CS (<.001).
↵d Healthy controls vs remitted CS (.043); healthy controls vs cured CS (.006).
↵e Healthy controls vs active CS (.015); healthy controls vs remitted CS (.001).
↵f Healthy controls vs remitted CS (.015).
↵g Body mass index: normal, ≤25; overweight, 25–30; obesity, >30.